These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7011748)

  • 21. Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity.
    Olefsky JM; Reaven GM
    Diabetes; 1977 Jul; 26(7):680-8. PubMed ID: 873075
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 23. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
    Bohannon NV; Lorenzi M; Grodsky GM; Karam JH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):459-62. PubMed ID: 7054228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.
    Lord JM; White SI; Bailey CJ; Atkins TW; Fletcher RF; Taylor KG
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):830-1. PubMed ID: 6403102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exacerbation of diabetes mellitus by antibodies to exogenous insulin.
    Rendell M; Hamilton RG; Drew HM; Adkinson NF
    Am J Med Sci; 1981; 282(1):18-26. PubMed ID: 7270568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects: comparison with pork and human pancreatic insulin.
    Bachmann W; Sieger C; Lacher F; Lotz N
    Diabetes Care; 1981; 4(2):215-9. PubMed ID: 7011730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin receptor binding to blood cells: an outdated concept for clinical studies on insulin resistance?
    Müller MJ
    Klin Wochenschr; 1987 Oct; 65(20):949-54. PubMed ID: 3323643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dependence of insulin degradation by intact erythrocytes on receptor binding in diabetic patients.
    Marttinen A
    Exp Clin Endocrinol; 1986 Nov; 88(1):71-5. PubMed ID: 3545859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of receptor systems in patients with diabetes mellitus].
    Zamaklar M; Ribarac-Stepić N; Devecerski M; Lalić N; Drezlić M
    Srp Arh Celok Lek; 1986 Sep; 114(9):859-66. PubMed ID: 3544245
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes.
    Murugan P; Pari L; Rao CA
    J Biosci; 2008 Mar; 33(1):63-72. PubMed ID: 18376071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy of insulin-independent diabetes mellitus: general considerations.
    Lebovitz HE; Feinglos MN
    Metabolism; 1980 May; 29(5):474-81. PubMed ID: 6990182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical usefulness of the determination of erythrocyte insulin receptors].
    Grigorescu F; Lambert B; De Meyts P
    Journ Annu Diabetol Hotel Dieu; 1982; ():31-4. PubMed ID: 7098254
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial hyperinsulinemia complicated by extreme insulin resistance during pregnancy: a probable postreceptor defect.
    Plehwe WE; Maitland JE; Williams PF; Shearman RP; Turtle JR
    J Clin Endocrinol Metab; 1985 Jul; 61(1):68-77. PubMed ID: 3889041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin binding on erythrocytes in unsatisfactorily controlled obese diabetics (type 2) and nonobese diabetics (type 1).
    Páv J; Hilgertová J; Srámková J
    Exp Clin Endocrinol; 1985 Aug; 86(1):53-60. PubMed ID: 3902484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estimation of insulin efficacy in obesity by the response of blood insulin and glucose to intravenous tolbutamide].
    Vague P; Depieds R; Boeuf G; Leroy C; Perrimond D; Codaccioni JL; Vague J
    Ann Endocrinol (Paris); 1966; 27(6):820-9. PubMed ID: 5973133
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glycemia and plasma insulin under the influence of tolbutamide and HB 419 in normal and diabetic persons].
    Quabbe HJ; Kliems G
    Journ Annu Diabetol Hotel Dieu; 1969; 10():301-9. PubMed ID: 5376989
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased erythrocyte insulin receptor binding in diabetic man with chronic renal failure.
    Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
    Horm Metab Res; 1980 Aug; 12(8):414-5. PubMed ID: 6997168
    [No Abstract]   [Full Text] [Related]  

  • 40. Receptors, antireceptor antibodies and mechanisms of insulin resistance.
    Flier JS; Kahn CR; Roth J
    N Engl J Med; 1979 Feb; 300(8):413-9. PubMed ID: 366414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.